Teva Pharmaceutical Industries News

Teva Pharmaceutical Industries Ltd., France's Les Laboratoires Servier and other generic-drug makers face European Union antitrust probes of agreements that may have delayed the sale of a blood pressure medication.

Teva Pharmaceutical Industries Ltd. announced today that it will release its second quarter 2009 financial results on Tuesday, July 28, 2009.

Teva Pharmaceutical Industries Ltd. said Tuesday it stopped shipping a generic version of Johnson & Johnson's birth control pill Ortho Tri-Cyclen. The world's largest generic drug maker said it agreed to stop shipping the drug pending a preliminary injunction hearing in a patent infringement lawsuit from Johnson & Johnson.

LONDON-- --07 July 2009 Issue: Network Rail Infrastructure Fin. Series 43 XS0370068669 Pursuant to our appointment as Agent for the above stated issue, please be - 07/07/2009 - 08:42 AM WellCentive Approved by CMS for the 2009 PQRI Program ATLANTA-- --WellCentive has been approved by the Centers for Medicare and Medicaid Services as a vendor for ...

The correlation between contraception and the recession is significant. Women are now much more concerned about preventing pregnancy during the economic downturn .

Follow-on biologics -- generic versions of protein-based biologic drugs -- can already be approved in the EU and Japan, and a pathway for approval in the U.S. seems likely, given the way politicians cite follow-on biologics as one of the potential saviors of the health-care system.

Leverkusen.- Bayer Schering Pharma AG, Germany and Bayer HealthCare Pharmaceuticals Inc.

The GCFR Overall Gauge of Watson Pharmaceuticals, Inc. decreased from 56 to 41 of the 100 possible points in the first quarter of 2009.

Jun 26, 2009 Intevac, Inc. closed at $8.17 on a volume of 266,091 shares. Intevac Receives Order for Second 200 Lean Gen II Etch and Deposition System for Patterned Media Development SANTA CLARA, Calif., Jun 29, 2009 -- Intevac, Inc.

On Monday, a consortium of drug companies lobbied the FDA, saying, "products that include acetaminophen should stay on the market" despite concerns of widespread liver damage.

The agreement is intended to efficiently rescue and redirect the clinical development of discontinued drug candidates which have been shelved by their originators pharmaceutical companies, using Optimata's bio-simulation technology, the Optimata Virtual Patient .

Investors in a highly regulated industry like drug development need to be conscious of what the regulators, the Food and Drug Administration in this case, are up to.

Teva Pharmaceutical Industries Ltd. and Antares Pharma Inc. said Monday the companies received Food and Drug Administration approval for use of the human growth hormone Tev-Tropin in a needle-free injection system.

If a health-care reform package makes it through Congress this year, it's safe to assume it will include a defined regulatory pathway for generic biotechnology drugs.

The Federal Trade Commission is an equal opportunity hater. Earlier this month it came out with a report arguing for limited patent protection for drugs made by biotech companies.

Europe's got 'em. Now Japan has 'em. When will the U.S. follow suit? We're talking about follow-on biologics, also known as "biosimilars," depending on the country of origin .

Reuters notes: The ruling from the Commercial Court in Dublin is a victory for Teva Pharmaceutical Industries, whose Ivax unit had challenged the combination patent for Seretide .

Teva Pharmaceuticals USA lashed out Wednesday at the Federal Trade Commission, which a day earlier leveled its own criticism of what its chairman described as "pay-for-delay" deals between manufacturers of branded drug products and generic drug companies.

The Obama administration's push to drive healthcare costs down may not be all bad news for the biopharmaceutical industry.

Teva Pharmaceutical Industries Ltd., the Jerusalem drugmaker, exercised an option to complete an investment and license for Andromeda Biotech Ltd.'s DiaPep277, a late-stage-development treatment for Type 1 diabetes.